Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling. | Biomedicines | 2023 | 37239147 | PubTator, text mining | PubMed |
| Approach to Pancreatic Head Mass in the Background of Chronic Pancreatitis. | Diagnostics (Basel) | 2023 | 37238280 | PubTator, text mining | PubMed |
| Copper exerts cytotoxicity through inhibition of iron-sulfur cluster biogenesis on ISCA1/ISCA2/ISCU assembly proteins. | Free Radic Biol Med | 2023 | 37225108 | PubTator, text mining | PubMed |
| Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis. | Front Immunol | 2023 | 37215133 | PubTator, text mining | PubMed |
| An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma. | Mol Carcinog | 2023 | 37212487 | PubTator, text mining | PubMed |
| [Clinical and genetic analysis of three children with Menkes disease due to variants of ATP7A gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37212000 | PubTator, text mining | PubMed |
| Genetic analysis of cuproptosis subtypes and immunological features in severe influenza. | Microb Pathog | 2023 | 37207785 | PubTator, text mining | PubMed |
| Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer. | Front Oncol | 2023 | 37205181 | PubTator, text mining | PubMed |
| Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases. | Chem Soc Rev | 2023 | 37203389 | PubTator, text mining | PubMed |
| Metals in Alzheimer's Disease. | Biomedicines | 2023 | 37189779 | PubTator, text mining | PubMed |
| Copper-related genes predict prognosis and characteristics of breast cancer. | Front Immunol | 2023 | 37180167 | PubTator, text mining | PubMed |
| Achievement of the Selectivity of Cytotoxic Agents against Cancer Cells by Creation of Combined Formulation with Terpenoid Adjuvants as Prospects to Overcome Multidrug Resistance. | Int J Mol Sci | 2023 | 37175727 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| APOE expression and secretion are modulated by mitochondrial dysfunction. | Elife | 2023 | 37171075 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines. | Front Mol Biosci | 2023 | 37168258 | PubTator, text mining | PubMed |
| 25KDa branched polyethylenimine increases interferon-γ production in natural killer cells via improving translation efficiency. | Cell Commun Signal | 2023 | 37161542 | PubTator, text mining | PubMed |
| Role of cuproptosis in understanding diseases. | Hum Cell | 2023 | 37154876 | PubTator, text mining | PubMed |
| Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints. | Front Immunol | 2023 | 37153542 | PubTator, text mining | PubMed |
| Case report: Two individuals with AEBP1-related classical-like EDS: Further clinical characterisation and description of novel AEBP1 variants. | Front Genet | 2023 | 37144134 | PubTator, text mining | PubMed |
| Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. | BMC Med Genomics | 2023 | 37143115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=22